Emerging RNA-Based Therapeutic and Diagnostic Options: Recent Advances and Future Challenges in Genitourinary Cancers

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Genitourinary tumors, including renal cell carcinoma, bladder cancer, and prostate cancer, are prevalent worldwide.
• Recent advancements in understanding oncogenic factors and molecular mechanisms have transformed their diagnosis and treatment.
• Non-coding RNAs (ncRNAs), such as microRNAs, long non-coding RNAs (lncRNAs), and circular RNAs, play a role in genitourinary cancer development and progression.

Purpose of the Study:

• To review the mechanisms of abnormal lncRNA expression in genitourinary tumors.
• To discuss the role of lncRNAs in the diagnostics, prognosis, and treatment of these cancers.
• To highlight the potential of lncRNAs as biomarkers and therapeutic targets.

Main Methods:

• Review of current literature on lncRNAs in genitourinary cancers.
• Analysis of molecular mechanisms involving lncRNA interactions with DNA, proteins, and other macromolecules.
• Exploration of genome sequencing data implicating ncRNAs in cancer phenotypes.

Main Results:

• Abnormal lncRNA expression is linked to the occurrence and progression of genitourinary cancers.
• lncRNAs interact with other biological macromolecules, influencing cancer phenotypes.
• Functional markers derived from lncRNA studies show potential for diagnostic and therapeutic applications.

Conclusions:

• lncRNAs are critical players in the molecular landscape of genitourinary tumors.
• Further research into lncRNA mechanisms can yield novel biomarkers for early diagnosis and effective treatment strategies.
• Targeting lncRNAs presents a promising avenue for future cancer therapies.